Home Medicine Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil
Article
Licensed
Unlicensed Requires Authentication

Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil

  • Suzana Nesi-França ORCID logo EMAIL logo , Rodrigo B. Silveira ORCID logo , Juliana Cristina R. Rojas Ramos ORCID logo , Adriane A. Cardoso-Demartini ORCID logo , Monica N. Lima Cat ORCID logo , Julienne A. R. de Carvalho ORCID logo , Rosana M. Pereira ORCID logo and Luiz De Lacerda ORCID logo
Published/Copyright: October 13, 2020

Abstract

Objectives

Adequate treatment of congenital hypothyroidism (CH) is required for normal growth and sexual development. To evaluate pubertal development in patients with permanent CH detected by a statewide Neonatal Screening Program of Paraná and, secondly, to evaluate adult height (AH) in a subgroup of patients.

Methods

Clinical, laboratory, and auxological data obtained from medical records of 174 patients (123 girls).

Results

Median chronological age (CA) at treatment initiation was 24 days, and mean initial levothyroxine dose was 11.7 ± 1.9 μg/kg/day; mean CA at puberty onset was 11.5 ± 1.3 years (boys) and 9.7 ± 1.2 years (girls); mean CA in girls who underwent menarche (n=81) was 12.1 ± 1.1 years. Thyroid-stimulating hormone (TSH) values above the normal range were observed in 36.4% of the boys and 32.7% of the girls on puberty onset, and in 44.6% around menarche. Among 15 boys and 66 girls who had reached the AH, the median height z-score value was significantly greater than the target height (TH) z-score value in boys (p=0.01) and in girls (p<0.001). Boys with normal TSH values at puberty onset had greater mean AH z-score compared with boys with TSH values above the normal range (p=0.04).

Conclusions

In this group, pubertal development in girls with CH was not different from that reported in healthy girls in the general Brazilian population. Boys with higher TSH at puberty onset may have an increased risk of not reaching their potential height compared with those with normal TSH during this period. In a subgroup who attained AH, the median AH z-score was greater than the median TH z-score.


Corresponding author: Suzana Nesi França, M.D., Ph.D., Professor of Pediatrics, Pediatric Endocrinology Unit, Department of Pediatrics, Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR), Rua Padre Camargo, 250, CEP 80060-240, Curitiba, PR, Brazil, E-mail:

Funding source: Conselho Nacional de Desenvolvimento Científico e Tecnológico

Award Identifier / Grant number: not available

Acknowledgments

Rodrigo Bruel da Silveira received funding for this study from the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq). We would like to thank the staff at Ecumenical Foundation for Protection of the Handicapped (Fundação Ecumênica de Proteção ao Excepcional, FEPE) for their outstanding job at all stages of the Neonatal Screening Program and the staff at UEP-UFPR for their assistance to patients and families.

  1. Research funding: This work was funded by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq).

  2. Authors contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. Suzana Nesi-França – Conception, design, execution, analysis and interpretation of data, review of the final version of the article; Rodrigo B. Silveira – Conception, design, execution, analysis and interpretation of data, review of the final version of the article; Juliana Cristina R. Rojas Ramos – Analysis and interpretation of data, review of the final version of the article; Adriane A. Cardoso-Demartini – Analysis and interpretation of data, review of the final version of the article; Monica N. Lima Cat – Conception, design, analysis and interpretation of data, review of the final version of the article; Julienne A. R. de Carvalho – Analysis and interpretation of data, review of the final version of the article; Rosana M. Pereira – Analysis and interpretation of data, review of the final version of the article; and Luiz De Lacerda – Conception, design, analysis and interpretation of data, review of the final version of the article.

  3. Competing interests: The authors have no potential conflicts of interest to report.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Human Research Ethics Committee of the Federal University of Paraná Clinical Hospital (protocol number 2398.005/2011-01).

References

1. LaFranchi, SH. Approach to the diagnosis and treatment of neonatal hypothyroidism. J Clin Endocrinol Metab 2011; 96: 2959–67. https://doi.org/10.1210/jc.2011-1175.Search in Google Scholar PubMed

2. LaFranchi, SH, Austin, J. How should we be treating children with congenital hypothyroidism. J Pediatr Endocrinol Metab 2007; 20: 559–78. https://doi.org/10.1515/jpem.2007.20.5.559.Search in Google Scholar PubMed

3. de Vries, L, Dickerman, Z. Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism detected by the neonatal screening program for CH – a longitudinal study. Clin Endocrinol 1997; 47: 649–54. https://doi.org/10.1046/j.1365-2265.1997.3181148.x.Search in Google Scholar PubMed

4. Salerno, M, Micillo, M, Di Maio, S, Capalbo, D, Ferri, P, Lettiero, T, et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol 2001; 145: 377–83. https://doi.org/10.1530/eje.0.1450377.Search in Google Scholar PubMed

5. Bain, P, Toublanc, JE. Adult height in congenital hypothyroidism: prognostic factors and the importance of compliance with treatment. Horm Res Paediatr 2002; 58: 136–42. https://doi.org/10.1159/000064489.Search in Google Scholar PubMed

6. Adachi, M, Asakura, Y, Tachibana, K. Final Height and pubertal growth in Japanese patients with congenital hypothyroidism detected by neonatal screening. Acta Paediatr 2003; 92: 698–703. https://doi.org/10.1111/j.1651-2227.2003.tb00603.x.Search in Google Scholar

7. Sato, H, Sasaki, N, Aoki, K, Kuroda, Y, Kato, T. Growth of patients with congenital hypothyroidism detected by neonatal screening in Japan. Pediatr Int 2007; 49: 443–6. https://doi.org/10.1111/j.1442-200x.2007.02395.x.Search in Google Scholar PubMed

8. Agulló, AG, Vicens-Calvet, E, Lezcano, AC, Esteve, MB, Vilalta, NP. Growth and maturation in the patients with congenital hypothyroidism detected by the neonatal screening program in Catalonia, Spain (1986–1997). Med Clin (Barc) 2010; 134: 287–95. https://doi.org/10.1016/j.medcli.2009.07.048.Search in Google Scholar PubMed

9. Lee, J, Lee, J, Lee, DH. Final height of Korean patients with early treated congenital hypothyroidism. Korean J Pediatr 2018; 61: 221–5. https://doi.org/10.3345/kjp.2018.61.7.221.Search in Google Scholar PubMed PubMed Central

10. Grant, DB. Growth in early treated congenital hypothyroidism. Arch Dis Child 1994; 70: 464–8. https://doi.org/10.1136/adc.70.6.464.Search in Google Scholar PubMed PubMed Central

11. Wong, SC, Ng, SM, Didi, M. Children with congenital hypothyroidism are at risk of adult obesity due to early adiposity rebound. Clin Endocrinol 2004; 61: 441–6. https://doi.org/10.1111/j.1365-2265.2004.02116.x.Search in Google Scholar PubMed

12. Chen, SY, Lin, SJ, Lin, SH, Chou, YY. Early adiposity rebound and obesity in children with congenital hypothyroidism. Pediatr Neonatol 2013; 54: 107–12. https://doi.org/10.1016/j.pedneo.2012.10.008.Search in Google Scholar PubMed

13. Léger, J, Ecosse, E, Roussey, M, Lanoë, JL, Larroque, B, The French Congenital Hypothyroidism Group Subtle health impairment and socioeducational attainment in young adult patients with congenital hypothyroidism diagnosed by neonatal screening: a longitudinal population-based cohort study. J Clin Endocrinol Metab 2011; 96: 1771–82. https://doi.org/10.1210/jc.2010-2315.Search in Google Scholar PubMed

14. Léger, J, Olivieri, A, Donaldson, M, Torresani, T, Krude, H, Van Vliet, G, et al. Congenital Hypothyroidism Consensus Conference Group European society for paediatric endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 2014; 99: 363–84. https://doi.org/10.1210/jc.2013-1891.Search in Google Scholar PubMed PubMed Central

15. Nesi-França, S. Anthropometric evaluation of patients with congenital hypothyroidism diagnosed by neonatal screening; 2006. Available from: https://acervodigital.ufpr.br/bitstream/handle/1884/7700/suzana_final.pdf?sequence=1&isAllowed=y.Search in Google Scholar

16. Silveira, RB, Marques-Pereira, R, Lara, F, Hertz, MT, Sandrini, R, De Lacerda, L, et al. Preliminary data of puberty and final height of patients with congenital hypothyroidism detected by neonatal screening. Abstracts of the XXI annual meeting of the Latin American Society for Pediatric Endocrinology. Horm Res Paediatr 2010; 74: 1–24, https://doi.org/10.1159/000320138.Search in Google Scholar

17. Dassie-Leite, AP, Behlau, M, Nesi-França, S, Lima, MN, de Lacerda, L. Vocal Evaluation of Children with Congenital Hypothyroidism. J Voice 2018; 32: 770.e11–e19. https://doi.org/10.1016/j.jvoice.2017.08.006.Search in Google Scholar PubMed

18. Onis, M, Onyango, AW, Borghi, E, Siyam, A, Nishida, C, Siekmann, J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Org 2007; 85: 660–7. https://doi.org/10.2471/blt.07.043497.Search in Google Scholar PubMed PubMed Central

19. Ruíz, JMJ, Domingos, MT, Pelaez, JM, Lima, MR, Kraemer, GC, Chiamolera, MI, et al. A quarter-of-century of the congenital hypothyroidism screening program of the State of Parana (Southern Brazil): prevalence and etiology. Individual abstracts for the 10th international meeting of pediatric endocrinology: free communication and poster sessions abstracts. Horm Res Paediatr 2017;88(1 Suppl):1–628, https://doi.org/10.1159/000481424.Search in Google Scholar PubMed

20. Ramos, JCR, De Lacerda, F, Demartini, AAC, Silveira, RB, Pereira, RM, Sandrini, R, et al. Clinical and laboratory features of children and adolescents with congenital hypothyroidism due to dyshormonogenesis in southern Brazil. Arq Bras Endocrinol Metab 2012; 56: 201–8. https://doi.org/10.1590/s0004-27302012000300009.Search in Google Scholar PubMed

21. Harris, KB, Pass, KA. Increase in congenital hypothyroidism in New York State and in United States. Mol Genet Metab 2007; 91: 268–77. https://doi.org/10.1016/j.ymgme.2007.03.012.Search in Google Scholar PubMed

22. Cavarzere, P, Castanet, M, Polak, M, Raux-Dema, MC, Cabrol, S, Carel, JC, et al. Clinical description of infants with congenital hypothyroidism and iodide organification defects. Horm Res Paediatr 2008; 70: 240–8. https://doi.org/10.1159/000151597.Search in Google Scholar PubMed

23. Wasniewska, M, Salerno, M, Cassio, A, Corrias, A, Aversa, T, Zirilli, G, et al. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol 2009; 160: 417–21. https://doi.org/10.1530/eje-08-0625.Search in Google Scholar

24. Cerbone, M, Bravaccio, C, Capalbo, D, Polizzi, M, Wasniewska, M, Cioffi, D, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 2011; 164: 591–7. https://doi.org/10.1530/eje-10-0979.Search in Google Scholar

25. Bona, G, Prodam, F, Monzani, A. Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol 2013; 5: 23–8. https://doi.org/10.4274/jcrpe.851.Search in Google Scholar PubMed PubMed Central

26. CensoInstituto Brasileiro de Geografia e Estatística (IBGE); 2010. Available from: http://censo2010.ibge.gov.br.Search in Google Scholar

27. Delvecchio, M, Salerno, M, Acquafredda, A, Zecchino, C, Fico, F, Manca, F, et al. Factors predicting final height in early treated congenital hypothyroid patients. Clin Endocrinol 2006; 5: 693–7. https://doi.org/10.1111/j.1365-2265.2006.02651.x.Search in Google Scholar PubMed

28. Castilho, SD, Saito, MI, Barros Filho, AA. Post-menarcheal growth in a cohort of Brazilian girls. Arq Bras Endocrinol Metab 2005; 49: 971–7. https://doi.org/10.1590/s0004-27302005000600018.Search in Google Scholar PubMed

29. Delvecchio, M, Vigone, MC, Wasniewska, M, Weger, G, Lapolla, R, Popolo, PP, et al. Final height in Italian patients with congenital hypothyroidism detected by neonatal screening: a 20-year observational study. Ital J Pediatr 2015; 41: 82. https://doi.org/10.1186/s13052-015-0190-y.Search in Google Scholar PubMed PubMed Central

Received: 2020-05-16
Accepted: 2020-09-13
Published Online: 2020-10-13
Published in Print: 2020-11-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. The influence of growth hormone therapy on the cardiovascular system in Turner syndrome
  4. Original Articles
  5. Clinical utility of urinary gonadotrophins in hypergonadotrophic states as Turner syndrome
  6. Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children
  7. Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment
  8. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes
  9. Frequency of thyroid dysfunction in pediatric patients with congenital heart disease exposed to iodinated contrast media – a long-term observational study
  10. Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test
  11. Clinical relevance of T lymphocyte subsets in pediatric Graves’ disease
  12. Long-term follow-up of differentiated thyroid carcinoma in children and adolescents
  13. A quality improvement project for managing hypocalcemia after pediatric total thyroidectomy
  14. Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil
  15. Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma
  16. BRAFV600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation
  17. Case Reports
  18. Pseudohypoparathyroidism type 1B (PHP1B), a rare disorder encountered in adolescence
  19. Impaired glucose homeostasis and a novel HLCS pathogenic variant in holocarboxylase synthetase deficiency: a report of two cases and brief review
  20. Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature
  21. Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism
  22. Non-classical lipoid adrenal hyperplasia presenting as hypoglycemic seizures
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0285/html
Scroll to top button